Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging developments in RNA therapeutics.

Martin L Read1, Paul J Farrow, Leonard W Seymour

  • 1University of Oxford, Department of Clinical Pharmacology, Radcliffe Infirmary, Woodstock Road, Oxford, OX2 6HE, UK. martin.read@clinpharm.ox.ac.uk

Expert Opinion on Therapeutic Targets
|April 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disulfiram metabolite Cu(DDC)<sub>2</sub> enhances radionuclide uptake in vivo revealing insights into tumoural ablation resistance.

EBioMedicine·2026
Same author

Targeting Src tyrosine kinase to enhance radioiodide uptake in breast cancer.

Endocrine-related cancer·2025
Same author

T cell engagers: expanding horizons in oncology and beyond.

British journal of cancer·2025
Same author

The implications of oncolytic viruses targeting fibroblasts in enhancing the antitumoural immune response.

Heliyon·2024
Same author

Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells.

Journal for immunotherapy of cancer·2024
Same author

AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genes.

Scientific reports·2023
Same journal

The biological role of CCR4 and its ligands CCL17 and CCL22 in atopic dermatitis: therapeutic implications and future directions.

Expert opinion on therapeutic targets·2026
Same journal

Hepatocyte nuclear factor 4α - prospects for therapeutic targeting.

Expert opinion on therapeutic targets·2026
Same journal

The role of bile acid receptors in cholestatic liver disease: pathophysiological insights and therapeutic advances.

Expert opinion on therapeutic targets·2026
Same journal

Molecular insights for targeting the Nrf1 pathway in hepatocellular carcinoma.

Expert opinion on therapeutic targets·2026
Same journal

Transient receptor potential (TRP) channels: an emerging therapeutic target for the treatment of cardiac hypertrophy.

Expert opinion on therapeutic targets·2026
Same journal

The AT<sub>2</sub> receptor as a potential target for autosomal dominant polycystic kidney disease therapy?

Expert opinion on therapeutic targets·2026
See all related articles

Novel RNA therapeutics show promise for treating diseases by silencing gene expression and utilizing aptamers for diagnostics and therapeutics. Advances include RNA interference for cancer and viral infections, and safer drug design with aptamers.

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology and Pharmaceutical Sciences

Background:

  • Recent advancements in RNA therapeutics offer potential for treating various human diseases.
  • The second International Conference on RNA in Drug Development highlighted novel RNA-based technologies.

Framework:

  • Exploration of RNA interference (RNAi) for gene silencing, targeting cancer and viral infections.
  • Development of aptamers for diverse diagnostic and therapeutic applications.
  • Investigation of small molecules for targeting RNA.

Implementation:

  • RNA interference (RNAi) strategies for systemic gene silencing.
  • Aptamer-based drug design incorporating antidote oligonucleotides for controlled therapeutic activity.
  • Clinical and preclinical progress of ribozymes and aptamers, focusing on improved serum half-life.

Related Experiment Videos

Implications:

  • RNA-based therapeutics present a promising new frontier in medicine.
  • Enhanced drug design and delivery methods are crucial for clinical success.
  • Further development could lead to effective treatments for currently intractable diseases.